News > Press Release
Alzheimer's Disease Research
BrightFocus Foundation Lauds Bill Gates Alzheimer’s Initiative
BrightFocus Editorial Staff
The following statement was issued today by BrightFocus Foundation President and CEO Stacy Pagos Haller:
“BrightFocus Foundation lauds today’s historic announcement by Bill Gates of his $50 million investment in the Dementia Discovery Fund. A charitable act of this magnitude is a profound example of the courage and the power of philanthropy to tackle society’s most pressing challenges.
The statistics of Alzheimer’s are staggering – 5 million Americans currently with the disease and a new diagnosis every 66 seconds – but the human toll is far greater. Who among us does not know someone robbed of a lifetime of memories, or know someone caring for a loved one facing a disease with no effective cure or treatment?
In our view, Bill Gates’ approach is the right one – pursue the widest array of scientific ideas as possible. It would be a tragic disservice to the millions impacted by this disease to allow roadblocks on innovation or narrow the parameters of scientific ingenuity and discovery. The Alzheimer’s crisis is just too urgent to think small or narrow.
BrightFocus commends the strong leadership of Bill Gates, and looks forward to working side-by-side to defeat Alzheimer’s disease.”
BrightFocus Foundation, through its Alzheimer’s Disease Research program, is currently supporting over 100 projects worldwide, in addition to its Alzheimer’s Fast Track which helps shape the next generation of scientists. For more information, please visit www.BrightFocus.org
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
- Industry News
News
Related Articles and Information
Press Release
BrightFocus Foundation Receives $3.2 Million Grant for Alzheimer’s Research
BrightFocus Foundation received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants.
Press Release
Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome, New Report Finds
Report shows that boosting research investment into the wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years.
Article
FDA Approves Eli Lilly’s Alzheimer’s Treatment
Another disease-modifying Alzheimer's therapy hits the market.
Article
Upcoming Alzheimer’s Drug Receives Unanimous Support from FDA Advisory Committee
An FDA decision on Eli Lilly's donanemab is expected in the coming months.
